Thank you, Mr. Chair.
Thank you, MP Sidhu.
The previous questioners were asking for examples of when the Patented Medicine Prices Review Board as well as the pan-Canadian Pharmaceutical Alliance were able to provide lower prices to Canadians. I think most MPs would recall a period of time in which we were all advocating for Trikafta, a cystic fibrosis drug, which is now available to Canadians at a fair cost because of the process that it went through.
In my riding, I have a young guy named Liam, who is getting stronger and stronger by the day. He's an incredible young man. He's an author. He's an advocate for those living with cystic fibrosis. That pan-Canadian Pharmaceutical Alliance was responsible for negotiating prices on—